No­vo Nordisk's pick for new chair­man sig­nals its on­go­ing pur­suit of M&A deals

De­spite what its failed bid for Abl­ynx may sug­gest, No­vo Nordisk is dead se­ri­ous about M&A — and it is bring­ing on a new chair­man who helps show­case that point.

The Dan­ish com­pa­ny is set to ap­point vet­er­an oil and gas ex­ec and M&A gu­ru Helge Lund to the role to­day, Reuters re­ports, at a time the di­a­betes gi­ant is seek­ing to boost its blood prod­ucts busi­ness dur­ing a down­turn for the di­a­betes busi­ness. Lund re­places Goran An­do, who de­cid­ed not to seek re-elec­tion af­ter five years in the job.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.